| Product Code: ETC10600389 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Human Immunodeficiency Virus Type Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Human Immunodeficiency Virus Type Market Revenues & Volume, 2021 & 2031F |
3.3 China Human Immunodeficiency Virus Type Market - Industry Life Cycle |
3.4 China Human Immunodeficiency Virus Type Market - Porter's Five Forces |
3.5 China Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 China Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
3.7 China Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.8 China Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 China Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Goals, 2021 & 2031F |
4 China Human Immunodeficiency Virus Type Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV/AIDS in China |
4.2.2 Government initiatives and funding for HIV prevention and treatment programs |
4.2.3 Technological advancements in HIV testing and treatment |
4.3 Market Restraints |
4.3.1 Stigma and discrimination associated with HIV/AIDS in China |
4.3.2 Limited access to healthcare services, especially in rural areas |
4.3.3 High cost of HIV treatment and medications |
5 China Human Immunodeficiency Virus Type Market Trends |
6 China Human Immunodeficiency Virus Type Market, By Types |
6.1 China Human Immunodeficiency Virus Type Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Antiretroviral Therapy, 2021 - 2031F |
6.1.4 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Pre-exposure Prophylaxis, 2021 - 2031F |
6.1.5 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-exposure Prophylaxis, 2021 - 2031F |
6.1.6 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Adjuvant Therapy, 2021 - 2031F |
6.2 China Human Immunodeficiency Virus Type Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.2.3 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Integrase Strand Transfer Inhibitors, 2021 - 2031F |
6.2.4 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.2.5 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 China Human Immunodeficiency Virus Type Market, By Delivery Method |
6.3.1 Overview and Analysis |
6.3.2 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.5 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.4 China Human Immunodeficiency Virus Type Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 China Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-Positive Adults, 2021 - 2031F |
6.4.3 China Human Immunodeficiency Virus Type Market Revenues & Volume, By High-Risk Populations, 2021 - 2031F |
6.4.4 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Healthcare Workers, 2021 - 2031F |
6.4.5 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Pregnant Women, 2021 - 2031F |
6.5 China Human Immunodeficiency Virus Type Market, By Treatment Goals |
6.5.1 Overview and Analysis |
6.5.2 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.3 China Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 China Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-Exposure Prevention, 2021 - 2031F |
6.5.5 China Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-1 Transmission Prevention, 2021 - 2031F |
7 China Human Immunodeficiency Virus Type Market Import-Export Trade Statistics |
7.1 China Human Immunodeficiency Virus Type Market Export to Major Countries |
7.2 China Human Immunodeficiency Virus Type Market Imports from Major Countries |
8 China Human Immunodeficiency Virus Type Market Key Performance Indicators |
8.1 Percentage of population tested for HIV annually |
8.2 Number of new HIV infections reported each year |
8.3 Rate of HIV/AIDS-related mortality |
8.4 Funding allocated by the government for HIV prevention and treatment programs |
8.5 Number of healthcare facilities offering HIV testing and treatment services |
9 China Human Immunodeficiency Virus Type Market - Opportunity Assessment |
9.1 China Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 China Human Immunodeficiency Virus Type Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
9.3 China Human Immunodeficiency Virus Type Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.4 China Human Immunodeficiency Virus Type Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 China Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Goals, 2021 & 2031F |
10 China Human Immunodeficiency Virus Type Market - Competitive Landscape |
10.1 China Human Immunodeficiency Virus Type Market Revenue Share, By Companies, 2024 |
10.2 China Human Immunodeficiency Virus Type Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here